logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Helmi Sulaiman

Universiti Malaya
H指数:11
被引数:1,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons

铜绿假单胞菌血流感染中cefiderocol与标准疗法的随机对照试验：基于DOOR和广义成对比较的获益与风险评估

Clinical Infectious Diseases
IF7.3
2026-09-070
PRE
Melissa J Hardy; Patrick N A Harris; Yin Mo; Mark D Chatfield; Helmi Sulaiman; Po-Yu Liu; Mesut Yilmaz; Zeti Norfidiyati Salmuna; Mohd Zulfakar Mazlan; Siriluck Anunnatsiri; Rujipas Sirijatuphat; Darunee Chotiprasitsakul; David C Lye; Jyoti Somani; Shirin Kalimuddin; Abdullah T Aslan; Visanu Thamlikitkul; Yi-Tzu Lee; Ya-Sung Yang; Yi-Tsung Lin; Ong Hang Cheng; Chien-Hao Tseng; Sophia Archuleta; Yvonne Fu Zi Chan; Clinton M G Colaco; David L Paterson
Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections

多药耐药鲍曼不动杆菌和铜绿假单胞菌感染危重患者中多黏菌素B的群体药代动力学

International Journal of Antimicrobial Agents
IF4.6
2026-04-210
OAAI
Puteri Juanita Zamri; Saskia A. Wölky; Maria P. Hernandez-Mitre; Xin Liu; M. Shahnaz Hasan; Izyani Md Shariff; Helmi Sulaiman; Steven C. Wallis; Chandra Datta Sumi; Suzanne L. Parker; Fekade Bruck Sime; Jason A. Roberts; Mohd Hafiz Abdul-Aziz
Safety and efficacy of azithromycin-containing regimen as an intermittent preventive therapy for malaria in pregnant women: a systematic review and meta-analysis of randomized controlled trials

含阿奇霉素方案作为间歇预防性抗疟治疗在孕妇中的安全性与有效性：一项随机对照试验的系统评价与Meta分析

JOURNAL OF TRAVEL MEDICINE
IF6.4
2025-12-010
PRE
Lin, I-Fan; Sulaiman, Helmi; Tran, Van Khoi; Basri, Sazali; Pham, Chi Thanh; Nguyen, Ly Minh Duy; Tey, Mei Ying; Wu, Chun Lok; Tam, Ka-Wai; Loh, El-Wui
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

美罗培南在第一天给药剂量优化及在无显著肾功能损害的重症患者的稳态给药

Scientific Reports
IF3.9
2025-10-290
OA
Helmi Sulaiman; Muhammad Azrai Rozali; Santosh K. S. Adiraju; M. Shahnaz Hasan; Janattul A. Jamal; Xin Liu; Mohd-Basri Mat-Nor; Mohd Zulfakar Mazlan; Mohamad Irfan Othman-Jailani; Zeti Norfidiyati Salmuna; Steven C. Wallis; Jason A. Roberts; Mohd H. Abdul-Aziz
Correction: D-PRISM: a global survey-based study to assess diagnostic and treatment approaches in pneumonia managed in intensive care

更正：D-PRISM：一项基于全球调查的研究，旨在评估在重症监护中管理的肺炎的诊断和治疗策略。

Critical Care
IF9.3
2025-10-180
OAAI
Luis Felipe Reyes; Cristian C. Serrano‑Mayorga; Zhongheng Zhang; Isabela Tsuji; Gennaro De Pascale; Valeria Enciso Prieto; Mervyn Mer; Elyce Sheehan; Prashant Nasa; Goran Zangana; Kostoula Arvaniti; Alexis Tabah; Gentle Sunder Shrestha; Hendrik Bracht; Arie Zainul Fatoni; Khalid Abidi; Helmi bin Sulaiman; Vandana Kalwaje Eshwara; Liesbet De Bus; Yoshiro Hayashi; Pervin Korkmaz; Ali Ait Hssain; Niccolo Buetti; Qing Yuan Goh; Arthur Kwizera; Despoina Koulenti; Nathan D. Nielsen; Pedro Povoa; Otavio Ranzani; Jordi Rello; Andrew Conway Morris
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial

西他赛尔 versus 标准疗法用于医院获得性和 healthcare-associated 革兰氏阴性细菌血流感染（GAME CHANGER 试验）：一项开放标签、平行组、随机试验

The Lancet Infectious Diseases
IF31
2025-10-060
PRE
David L Paterson; Helmi Sulaiman; Po-Yu Liu; Mark D Chatfield; Mesut Yilmaz; Zeti Norfidiyati Salmuna; Mohd Zulfakar Mazlan; Siriluck Anunnatsiri; Rujipas Sirijatuphat; Darunee Chotiprasitsakul; David C Lye; Jyoti Somani; Shirin Kalimuddin; Abdullah T Aslan; Visanu Thamlikitkul; Yi-Tzu Lee; Ya-Sung Yang; Yi-Tsung Lin; Wan Nurliyana Wan Ramli; Chien-Hao Tseng; Sophia Archuleta; Yvonne Fu Zi Chan; Brian M Forde; Hugh Wright; Adam G Stewart; Kay A Ramsay; Weiping Ling; Vicki Rossi; Tiffany M Harris-Brown; Patrick N A Harris
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia

马来西亚一家三级教学医院两年内耐甲氧西林金黄色葡萄球菌 (MRSA) 感染的患病率和MRSA菌血症的分子特征

BMC INFECTIOUS DISEASES
IF3
2017-04-1364
OAAI
Sit, Pik San; Teh, Cindy Shuan Ju; Idris, Nuryana; Sam, I-Ching; Omar, Sharifah Faridah Syed; Sulaiman, Helmi; Thong, Kwai Lin; Kamarulzaman, Adeeba; Ponnampalavanar, Sasheela
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Β-内酰胺类药物输注治疗严重脓毒症 (BLISS): 一项针对重症脓毒症患者的连续性与间歇性 β-内酰胺类药物输注治疗的前瞻性、双中心、开放性随机对照试验

INTENSIVE CARE MEDICINE
IF21.2
2016-01-11231
PREAI
Abdul-Aziz, Mohd H.; Sulaiman, Helmi; Mat-Nor, Mohd-Basri; Rai, Vineya; Wong, Kang K.; Hasan, Mohd S.; Abd Rahman, Azrin N.; Jamal, Janattul A.; Wallis, Steven C.; Lipman, Jeffrey; Staatz, Christine E.; Roberts, Jason A.

研究方向

暂未获取到该数据
M
Mohd H. Abdul‐Aziz
H 指数:26论文数:107被引数:4,870
S
Steven C. Wallis
H 指数:44论文数:246被引数:7,392
M
Mohd Zulfakar Mazlan
H 指数:13论文数:96被引数:1,354
D
Deirdre Ward
H 指数:21论文数:1,164被引数:7,206
M
Mohd Basri Mat Nor
H 指数:29论文数:266被引数:3,393
C
Chee Ken Chan
H 指数:8论文数:18被引数:255
P
Pauline Siew Mei Lai
H 指数:25论文数:128被引数:2,008
S
Sasheela Ponnampalavanar
H 指数:28论文数:139被引数:3,103
T
Thian Yin Lam
H 指数:2论文数:5被引数:9
H
H Connaughton
H 指数:0论文数:13被引数:0